Association between epidermal growth factor (EGF) and EGF receptor gene polymorphisms and end-stage renal disease and acute renal allograft rejection in a Korean population

References

• Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–1730.
   PubMed Web of Science ®Google Scholar
• Czyzewski L, Sanko-Resmer J, Wyzgal J, et al. Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant. 2014;19:576–585.
   PubMed Web of Science ®Google Scholar
• Kaplan B, Meier-Kriesche HU. Death after graft loss: an important late study endpoint in kidney transplantation. Am J Transplant. 2002;2(10):970–974.
   PubMed Web of Science ®Google Scholar
• Kamoun M. Cellular and molecular parameters in human renal allograft rejection. Clin Biochem. 2001;34(1):29–34.
   PubMed Web of Science ®Google Scholar
• Ramanathan V, Goral S, Helderman JH. Renal transplantation. Semin Nephrol. 2001;21(2):213–219.
   PubMed Web of Science ®Google Scholar
• Dorr CR, Oetting WS, Jacobson PA, et al. Genetics of acute rejection after kidney transplantation. Transpl Int. 2018;31(3):263–277.
   PubMed Web of Science ®Google Scholar
• Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 2004;4(3):378–383.
   PubMed Web of Science ®Google Scholar
• Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant. 2004;4(8):1289–1295.
   PubMed Web of Science ®Google Scholar
• Lamb KE, Lodhi S, Meier-Kriesche HU. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant. 2011;11(3):450–462.
   PubMed Web of Science ®Google Scholar
• Grandaliano G, Gesualdo L, Bartoli F, et al. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int. 2000;58(1):182–192.
   PubMed Web of Science ®Google Scholar
• Torres DD, Rossini M, Manno C, et al. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int. 2008;73(3):327–333.
   PubMed Web of Science ®Google Scholar
• Zepeda-Orozco D, Wen HM, Hamilton BA, et al. EGF regulation of proximal tubule cell proliferation and VEGF-A secretion. Physiol Rep. 2017;5(18):e13453. Epub 2017 Sep 27.
   PubMed Web of Science ®Google Scholar
• Stein-Oakley AN, Tzanidis A, Fuller PJ, et al. Expression and distribution of epidermal growth factor in acute and chronic renal allograft rejection. Kidney Int. 1994;46(4):1207–1215.
   PubMed Web of Science ®Google Scholar
• Li TF, Ren KW, Liu PF. Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls. DNA Cell Biol. 2012;31(4):568–574.
   PubMed Web of Science ®Google Scholar
• Sun S, Jin GJ, Zhao Y, et al. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis. Asian Pac J Cancer Prev. 2015;16(7):3009–3014.
   PubMedGoogle Scholar
• Melenhorst WB, Mulder GM, Xi Q, et al. Epidermal growth factor receptor signaling in the kidney: key roles in physiology and disease. Hypertension. 2008;52(6):987–993.
   PubMed Web of Science ®Google Scholar
• Rayego-Mateos S, Morgado-Pascual JL, Rodrigues-Diez RR, et al. Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation. J Pathol. 2018;244(2):227–241.
   PubMed Web of Science ®Google Scholar
• Flamant M, Bollee G, Henique C, et al. Epidermal growth factor: a new therapeutic target in glomerular disease. Nephrol Dial Transplant. 2012;27(4):1297–1304.
   PubMed Web of Science ®Google Scholar
• Chen J, Chen JK, Harris RC. Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury. Kidney Int. 2012;82(1):45–52.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen JK, Wang SW, et al. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol. 2003;14(12):3147–3154.
   PubMed Web of Science ®Google Scholar
• Ju W, Nair V, Smith S, et al. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med. 2015;7:316ra193.
   PubMed Web of Science ®Google Scholar
• Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1992;20(1):1–17.
   PubMed Web of Science ®Google Scholar
• Roufosse C, Simmonds N, Clahsen-van Groningen M, et al. A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology. Transplantation. 2018;102(11):1795–1814.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang W, Xu A, et al. Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China. Genet Test Mol Biomarkers. 2013;17(8):595–600.
   PubMed Web of Science ®Google Scholar
• Tian W, Zhang J, Zhang K, et al. A study of the functional significance of epidermal growth factor in major depressive disorder. Psychiatr Genet. 2012;22(4):161–167.
   PubMed Web of Science ®Google Scholar
• Kim SK, Park HK, Choi HS, et al. Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population. Int Neurourol J. 2016;20(4):363–370.
   PubMed Web of Science ®Google Scholar
• Bell GI, Fong NM, Stempien MM, et al. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucl Acids Res. 1986;14(21):8427–8446.
   PubMed Web of Science ®Google Scholar
• Durkin ME, Chakravarti S, Bartos BB, et al. Amino acid sequence and domain structure of entactin. Homology with epidermal growth factor precursor and low density lipoprotein receptor. J Cell Biol. 1988;107(6):2749–2756.
   PubMed Web of Science ®Google Scholar
• Mroczkowski B, Reich M, Chen K, et al. Recombinant human epidermal growth factor precursor is a glycosylated membrane protein with biological activity. Mol Cell Biol. 1989;9(7):2771–2778.
   PubMed Web of Science ®Google Scholar
• Wang L, Bo L, Yan T, et al. EGF rs11568835 G/A polymorphism is associated with increased risk of rheumatoid arthritis. Biomarkers. 2014;19(7):563–566.
   PubMed Web of Science ®Google Scholar
• Jin G, Miao R, Deng Y, et al. Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci. 2007;98(6):864–868.
   PubMed Web of Science ®Google Scholar
• Fenton SE, Groce NS, Lee DC. Characterization of the mouse epidermal growth factor promoter and 5'-flanking region. Role for an atypical TATA sequence. J Biol Chem. 1996;271(48):30870–30878.
   PubMed Web of Science ®Google Scholar
• Mullhaupt B, Feren A, Jones A, et al. DNA sequence and functional characterization of the human and rat epidermal growth factor promoter: regulation by cell growth. Gene. 2000;250(1-2):191–200.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tian T, Hu Z, et al. EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women. Breast Cancer Res Treat. 2008;111(2):321–327.
   PubMed Web of Science ®Google Scholar
• Bonin S, Donada M, Bussolati G, et al. A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients. Tumor Biol. 2016;37(6):7295–7303.
   PubMedGoogle Scholar
• Koh YW, Kim HJ, Kwon HY, et al. Q787Q EGFR Polymorphism as a Prognostic Factor for Lung Squamous Cell Carcinoma. Oncology. 2016;90(5):289–298.
   PubMed Web of Science ®Google Scholar
• Fahraeus R, Marin M, Olivares-Illana V. Whisper mutations: cryptic messages within the genetic code. Oncogene. 2016;35:3753–3759.
   PubMed Web of Science ®Google Scholar
• Nakazaki K, Kato Y, Taguchi T, et al. Heterozygous mutation (G/G–>G/A) at nt 2607 of the EGFR gene is closely associated with increases in EGFR copy number and mRNA half life, but impaired EGFR protein synthesis in squamous cell carcinomas of the head and neck – implication for gefitinib efficacy. Oncol Lett. 2010;1:1017–1020.
   PubMed Web of Science ®Google Scholar